The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

J Crohns Colitis. 2010 Feb;4(1):28-62. doi: 10.1016/j.crohns.2009.12.002. Epub 2010 Jan 15.

Authors

A Dignass¹, G Van Assche, J O Lindsay, M Lémann, J Söderholm, J F Colombel, S Danese, A D'Hoore, M Gassull, F Gomollón, D W Hommes, P Michetti, C O'Morain, T Oresland, A Windsor, E F Stange, S P L Travis; European Crohn's and Colitis Organisation (ECCO)

Collaborators

European Crohn's and Colitis Organisation (ECCO):
J-F Colombel, S Danese, A D'Hoore, A Dignass, M Gassull, F Gomollon, D Hommes, M Lemann, J Lindsay, P Michetti, C O'Morain, T Oresland, J Söderholm, E Stange, S P L Travis, G van Assche, A Windsor, Novacek, Reinisch, Tilg, De Vos, D'Haens, D'Hoore, Louis, Vermeire, van Assche, Vucelic, Lukas, Kolho, Allez, Beaugerie, Bouhnik, Carbonnel, Colombel, Lemann, Marteau, Baumgart, Dignass, Herrlinger, Jehle, Kiesslich, Koletzko, Ochsenkühn, Reinshagen, Stange, Sturm, O'Morain, Dotan, Ardizzone, Danese, Gionchetti, Guslandi, Kupcinskas, Hommes, Oldenburg, van der Woude, Escher, Portela, Gassull, Gomollon, Panes, Rimola, Oresland, Söderholm, Michetti, Motter, Rogler, Cole, Lindsay, Orchard, Windsor, Travis

Affiliation

¹ Department of Medicine I, Markus-Krankenhaus, Wilhelm-Epstein-Str. 4, D-60431 Frankfurt/Main, Germany. axel.dignass@fdk.info

PMID: 21122489
DOI: 10.1016/j.crohns.2009.12.002

No abstract available

Publication types

Consensus Development Conference

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Adult
Aminosalicylic Acids / therapeutic use
Anti-Bacterial Agents / therapeutic use
Anti-Inflammatory Agents / adverse effects
Anti-Inflammatory Agents / therapeutic use
Antibodies, Monoclonal / therapeutic use
Child
Constriction, Pathologic / surgery
Crohn Disease / pathology
Crohn Disease / therapy*
Diet Therapy
Humans
Immunosuppressive Agents / adverse effects
Immunosuppressive Agents / therapeutic use
Infliximab
Intestines / surgery
Methotrexate / therapeutic use
Purines / therapeutic use
Recurrence
Remission Induction
Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

Adrenal Cortex Hormones
Aminosalicylic Acids
Anti-Bacterial Agents
Anti-Inflammatory Agents
Antibodies, Monoclonal
Immunosuppressive Agents
Purines
Tumor Necrosis Factor-alpha
Infliximab
Methotrexate